Enzo Biochem Management
Management criteria checks 0/4
Enzo Biochem's CEO is Kara Cannon, appointed in Sep 2023, has a tenure of 1.17 years. total yearly compensation is $1.22M, comprised of 24.4% salary and 75.6% bonuses, including company stock and options. directly owns 0.53% of the company’s shares, worth $311.29K. The average tenure of the management team and the board of directors is 1.2 years and 1.1 years respectively.
Key information
Kara Cannon
Chief executive officer
US$1.2m
Total compensation
| CEO salary percentage | 24.4% |
| CEO tenure | 1.2yrs |
| CEO ownership | 0.5% |
| Management average tenure | 1.2yrs |
| Board average tenure | 1.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jul 31 2024 | n/a | n/a | -US$10m |
| Apr 30 2024 | n/a | n/a | -US$18m |
| Jan 31 2024 | n/a | n/a | -US$23m |
| Oct 31 2023 | n/a | n/a | -US$25m |
| Jul 31 2023 | US$1m | US$299k | -US$25m |
| Apr 30 2023 | n/a | n/a | -US$27m |
| Jan 31 2023 | n/a | n/a | -US$24m |
| Oct 31 2022 | n/a | n/a | -US$23m |
| Jul 31 2022 | US$769k | US$270k | -US$20m |
| Apr 30 2022 | n/a | n/a | -US$7m |
| Jan 31 2022 | n/a | n/a | US$300k |
| Oct 31 2021 | n/a | n/a | US$5m |
| Jul 31 2021 | US$426k | US$265k | US$8m |
| Apr 30 2021 | n/a | n/a | US$1m |
| Jan 31 2021 | n/a | n/a | -US$11m |
| Oct 31 2020 | n/a | n/a | -US$21m |
| Jul 31 2020 | US$371k | US$220k | -US$29m |
| Apr 30 2020 | n/a | n/a | -US$31m |
| Jan 31 2020 | n/a | n/a | US$2m |
| Oct 31 2019 | n/a | n/a | US$822k |
| Jul 31 2019 | US$379k | US$220k | US$2m |
| Apr 30 2019 | n/a | n/a | US$2m |
| Jan 31 2019 | n/a | n/a | -US$23m |
| Oct 31 2018 | n/a | n/a | -US$16m |
| Jul 31 2018 | US$342k | US$198k | -US$10m |
Compensation vs Market: Kara's total compensation ($USD1.22M) is above average for companies of similar size in the UK market ($USD369.71K).
Compensation vs Earnings: Kara's compensation has increased whilst the company is unprofitable.
CEO
Kara Cannon (55 yo)
1.2yrs
Tenure
US$1,221,793
Compensation
Ms. Kara Cannon serves as Chief Executive Officer at Enzo Biochem, Inc. from January 31, 2024 and serves as its Director from 2024 and served as its Interim CEO since September 5, 2023 until January 31, 20...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 1.2yrs | US$1.22m | 0.53% $ 311.3k | |
| Chief Financial Officer | 2yrs | US$453.56k | 0.037% $ 21.9k | |
| General Counsel | less than a year | no data | no data |
1.2yrs
Average Tenure
53yo
Average Age
Experienced Management: 0IHV's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | less than a year | US$1.22m | 0.53% $ 311.3k | |
| Independent Chairperson of the Board | 1.1yrs | no data | 0.034% $ 20.0k | |
| Independent Director | 2.8yrs | US$195.00k | 8.07% $ 4.8m |
1.1yrs
Average Tenure
55yo
Average Age
Experienced Board: 0IHV's board of directors are not considered experienced ( 1.1 years average tenure), which suggests a new board.